Attendees at the American Thoracic Society (ATS) 2025 International Conference highlight global networking, scientific advancements, and professional development at this year's meeting.
At the American Thoracic Society (ATS) 2025 International Conference, attendees shared how the conference is a representation of knowledge exchange, collaboration, and advancing medical understanding in the pulmonary and critical care fields.
Here is what the following attendees who spoke with The American Journal of Managed Care® during the meeting had to say about why they attend the event:
This transcript was lightly edited; captions were auto-generated.
Transcript
What do you enjoy most about attending ATS?
Goulet: I think my favorite thing about being here is just being able to interact with our pulmonary and critical care colleagues from all over the world, and just seeing sort of what's new in our world of pulmonary medicine.
Ramakrishnan: Just catching up with everyone, colleagues around the world, learning what they're all up to, and even just catching up see how their family is going. [I've] worked with most of them, online and over correspondence; it's nice to see people in person.
Komori: I think it's just always really exciting to see all of the new science, both on the clinical front and also on the early preclinical data that's here from a lot of the people who are trying to develop medicines. And it's nice to see how people are engaging also with patients.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More